Galimedix, Inc.
/ Key word(s): Conference
Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD 2026 Conference
05.03.2026 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Galimedix Therapeutics to present pr...